Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02286713
Official study title

PCORI-CER-1306-03385 Informed Decisions About Lung Cancer Screening

Study summary

Educational research study where goal is to test educational materials that help people make informed decisions about lung cancer screening.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedPatient Decision Aid and Standard Educational Information

Plus 1 other study approaches.

Who it may be forLung Cancer · Smoking Cessation

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 1, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?M.D. Anderson Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
M.D. Anderson Cancer Center
Interventions being studied
Behavioral: Patient Decision Aid; Behavioral: Standard Educational Information; Behavioral: Follow-Up Assessments: Questionnaires
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Men and women 55 to 77 years of age. 2. Participants must speak English. 3. Current smoker or quit smoking within the past 15 years. 4. At least a 30 pack-year smoking history.

Reasons someone may not be able to joinExclusion criteria

1\) History of lung cancer.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Information and Quality Healthcare (IQH)Ridgeland, Mississippi

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 1, 2021. Always confirm current availability with the study team.

View original record ↗